ProKidney Corp.
PROK
$1.75
-$0.03-1.69%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 893.00K | 744.00K | 527.00K | 306.00K | 76.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 893.00K | 744.00K | 527.00K | 306.00K | 76.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 893.00K | 744.00K | 527.00K | 306.00K | 76.00K |
| SG&A Expenses | 51.78M | 51.89M | 52.67M | 52.27M | 50.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 165.90M | 171.63M | 176.84M | 179.97M | 178.43M |
| Operating Income | -165.01M | -170.89M | -176.32M | -179.66M | -178.35M |
| Income Before Tax | -151.20M | -155.54M | -163.65M | -166.06M | -163.93M |
| Income Tax Expenses | 414.00K | 3.70M | 799.00K | -105.00K | -598.00K |
| Earnings from Continuing Operations | -151.61 | -159.24 | -164.45 | -165.95 | -163.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 82.63M | 88.21M | 91.98M | 97.53M | 102.15M |
| Net Income | -68.99M | -71.03M | -72.47M | -68.43M | -61.19M |
| EBIT | -165.01M | -170.89M | -176.32M | -179.66M | -178.35M |
| EBITDA | -158.43M | -164.58M | -170.19M | -173.73M | -172.92M |
| EPS Basic | -0.51 | -0.54 | -0.56 | -0.60 | -0.63 |
| Normalized Basic EPS | -0.09 | -0.07 | -0.05 | -0.01 | 0.07 |
| EPS Diluted | -0.51 | -0.54 | -0.56 | -0.60 | -0.63 |
| Normalized Diluted EPS | -0.09 | -0.07 | -0.05 | -0.01 | 0.07 |
| Average Basic Shares Outstanding | 535.70M | 522.91M | 514.09M | 459.27M | 391.24M |
| Average Diluted Shares Outstanding | 535.70M | 522.91M | 514.09M | 459.27M | 391.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |